Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Demo Page
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Biosimilar Preference List
Do Not Crush
High Cost Drugs
LASA
Non-Formulary
Therapeutic Interchange
REMS
Renal Dosing
Restricted
Questions & Suggestions (Position 3)
Hazardous Drugs
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Demo Page
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Biosimilar Preference List
Do Not Crush
High Cost Drugs
LASA
Non-Formulary
Therapeutic Interchange
REMS
Renal Dosing
Restricted
Questions & Suggestions (Position 3)
Hazardous Drugs
Search results for:
alirocumab
alirocumab
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Praluent Pen
SOLUTION, SUBCUTANEOUS
75 mg/mL; 150 mg/mL
Additional Information:
Policies and procedures
Recommend patient use own supply if needed in inpatient setting
Consults and Protocols
Additional information
Link to MyPraluent Hub
for SMN form
Praluent Formulary Review 2015
Last updated:
Apr. 21, 2026
High Cost Drugs:
AWP $270/75 mg; $1,250/300 mg
Restricted:
To clinic use
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Policies and procedures
Consults and Protocols
Additional information